Page last updated: 2024-08-17

cycloheximide and mg 262

cycloheximide has been researched along with mg 262 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, D; Dong, X; Dou, QP; Guo, H; Huang, H; Li, S; Li, X; Liu, J; Liu, N; Liu, S; Lu, X; Yang, C; Zhang, C; Zhao, C; Zhao, K; Zhou, P	1

Other Studies

1 other study(ies) available for cycloheximide and mg 262

Article	Year
Gambogic acid enhances proteasome inhibitor-induced anticancer activity. Cancer letters, 2011, Feb-28, Volume: 301, Issue:2 Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Boronic Acids; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Survival; Cycloheximide; Cysteine Proteinase Inhibitors; Drug Synergism; Humans; K562 Cells; Leupeptins; Male; Mice; Neoplasms, Experimental; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Synthesis Inhibitors; Signal Transduction; Transplantation, Homologous; Tumor Burden; Xanthones	2011

Article

Year

Gambogic acid enhances proteasome inhibitor-induced anticancer activity.

Cancer letters, 2011, Feb-28, Volume: 301, Issue:2

Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Boronic Acids; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Survival; Cycloheximide; Cysteine Proteinase Inhibitors; Drug Synergism; Humans; K562 Cells; Leupeptins; Male; Mice; Neoplasms, Experimental; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Synthesis Inhibitors; Signal Transduction; Transplantation, Homologous; Tumor Burden; Xanthones

2011